Xeris Biopharma Holdings, Inc. (XERS)
6.04
-0.03
(-0.49%)
USD |
NASDAQ |
Mar 05, 16:00
5.98
-0.06
(-0.99%)
Pre-Market: 08:41
Xeris Biopharma Holdings Cash from Investing (Quarterly) : -0.333M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | -11.84M |
| IDEXX Laboratories, Inc. | -28.13M |
| Harrow, Inc. | -4.73M |
| Vir Biotechnology, Inc. | 86.65M |
| ACADIA Pharmaceuticals, Inc. | -55.87M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 20.04M |
| Cash from Financing (Quarterly) | -0.266M |
| Free Cash Flow | 27.93M |
| Free Cash Flow Per Share (Quarterly) | 0.1095 |
| Free Cash Flow to Equity (Quarterly) | 19.27M |
| Free Cash Flow to Firm (Quarterly) | 26.86M |
| Free Cash Flow Yield | 2.76% |